A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)
Clinical trial NCT00405054 · TERMINATED
Trial details
- NCT number
- NCT00405054
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-06-01
- Enrollment
- 52
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.